In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Atrial fibrillation - Anticoagulation

Event : ESC Congress 2018

Topic : Atrial Fibrillation - Stroke Prevention

  • Session type : Moderated Posters
  • Date : 28 August 2018
  • Time : 10:05 - 10:55

7 presentations in this session

NOACs versus warfarin in atrial fibrillation patients and risk of dementia: a nationwide propensity-weighted cohort study

Event : ESC Congress 2018

  • Session : Atrial fibrillation - Anticoagulation
  • Speaker : M Soegaard (Aalborg,DK)

Thrombosis of left atrial appendage closure devices - What is the clinical impact?

Event : ESC Congress 2018

  • Session : Atrial fibrillation - Anticoagulation
  • Speaker : V Lekesova (Praha 5,CZ)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are